These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32511404)

  • 1. Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2.
    Liu L; Chopra P; Li X; Bouwman KM; Tompkins SM; Wolfert MA; de Vries RP; Boons GJ
    bioRxiv; 2021 Jan; ():. PubMed ID: 32511404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.
    Liu L; Chopra P; Li X; Bouwman KM; Tompkins SM; Wolfert MA; de Vries RP; Boons GJ
    ACS Cent Sci; 2021 Jun; 7(6):1009-1018. PubMed ID: 34235261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II.
    Wang X; Bie L; Gao J
    J Chem Inf Model; 2022 Feb; 62(3):656-667. PubMed ID: 35060381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner.
    Abdulsalam H; Li J; Loka RS; Sletten ET; Nguyen HM
    ACS Med Chem Lett; 2023 Oct; 14(10):1411-1418. PubMed ID: 37849547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants.
    Gelbach AL; Zhang F; Kwon SJ; Bates JT; Farmer AP; Dordick JS; Wang C; Linhardt RJ
    Front Mol Biosci; 2022; 9():912887. PubMed ID: 36046608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD.
    An Z; Bu C; Shi D; Chen Q; Zhang B; Wang Q; Jin L; Chi L
    Int J Biol Macromol; 2024 Feb; 259(Pt 1):129032. PubMed ID: 38159696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Clausen TM; Sandoval DR; Spliid CB; Pihl J; Painter CD; Thacker BE; Glass CA; Narayanan A; Majowicz SA; Zhang Y; Torres JL; Golden GJ; Porell R; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser B; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Leibel SL; Chanda SK; Schmidt AG; Godula K; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
    bioRxiv; 2020 Jul; ():. PubMed ID: 32699853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
    Prieto-Fernández E; Egia-Mendikute L; Vila-Vecilla L; Bosch A; Barreira-Manrique A; Lee SY; García-Del Río A; Antoñana-Vildosola A; Jiménez-Lasheras B; Moreno-Cugnon L; Jiménez-Barbero J; Berra E; Ereño-Orbea J; Palazon A
    Emerg Microbes Infect; 2021 Dec; 10(1):1065-1076. PubMed ID: 34013835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein.
    Chittum JE; Sankaranarayanan NV; O'Hara CP; Desai UR
    ACS Med Chem Lett; 2021 Nov; 12(11):1710-1717. PubMed ID: 34786180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Hu Y; Meng X; Zhang F; Xiang Y; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin and Pentosan Polysulfate Bind to the SARS-CoV-2 Spike Protein and Human ACE2 Receptor, Inhibiting Vero Cell Infection.
    Ennemoser M; Rieger J; Muttenthaler E; Gerlza T; Zatloukal K; Kungl AJ
    Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection.
    Zhang Q; Pavlinov I; Ye Y; Zheng W
    Front Med (Lausanne); 2024; 11():1364657. PubMed ID: 38618194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
    Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
    Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.
    Yue J; Jin W; Yang H; Faulkner J; Song X; Qiu H; Teng M; Azadi P; Zhang F; Linhardt RJ; Wang L
    Front Mol Biosci; 2021; 8():649575. PubMed ID: 34179075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics.
    Eilts F; Bauer S; Fraser K; Dordick JS; Wolff MW; Linhardt RJ; Zhang F
    Carbohydr Polym; 2023 Jan; 299():120167. PubMed ID: 36876764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    bioRxiv; 2021 Jun; ():. PubMed ID: 34230926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.